Himalaya Nutravedics India IPO Opens on September 22
Himalaya Nutravedics India is preparing to launch its SME IPO on September 22, 2026. The public issue will remain open until September 24, giving investors three days to place their bids. The shares are expected to be listed on the SME platform on September 29, subject to the completion of the allotment process.
The company operates in the Ayurvedic and nutraceutical products segment and is involved in manufacturing, marketing and distribution activities. It also undertakes contract manufacturing, giving it exposure to both its own products and third-party business.
Himalaya Nutravedics India IPO Details
| Particular | Details |
|---|---|
| IPO Open Date | September 22, 2026 |
| IPO Close Date | September 24, 2026 |
| Price Band | ₹100 – ₹106 |
| Issue Size | Approx. ₹26 crore |
| Issue Type | Book Built |
| Issue | Fresh Issue |
| Face Value | ₹10 |
| Lot Size | 1,200 Shares |
| Minimum Investment | ₹1,27,200 |
| Allotment | September 25, 2026 |
| Refund/Demat | September 28, 2026 |
| Expected Listing | September 29, 2026 |
| Registrar | KFin Technologies |
| Lead Manager | Nirbhay Capital Services |
The issue consists of approximately 25 lakh shares, with the proceeds going to the company rather than existing shareholders through an offer for sale.
Himalaya Nutravedics India IPO GMP Today
The latest available grey market data indicates a GMP of ₹0 for the Himalaya Nutravedics India IPO. At the upper price band of ₹106, this indicates no premium over the issue price based on the current unofficial grey-market indication.
However, GMP is an unofficial market indicator and can change before listing. It should therefore be viewed separately from the company's actual financial and operating performance.
Strong Financial Growth Before IPO
Himalaya Nutravedics India has reported significant growth over the last three financial years. Total revenue increased from ₹14.43 crore in FY2024 to ₹21 crore in FY2025 and ₹43.12 crore in FY2026. Profit after tax also increased from around ₹0.43 crore in FY2024 to ₹2.23 crore in FY2025 and ₹7.39 crore in FY2026.
| Particular | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
| Revenue | ₹14.43 Cr | ₹21.00 Cr | ₹43.12 Cr |
| PAT | ₹0.43 Cr | ₹2.23 Cr | ₹7.39 Cr |
| EBITDA | ₹0.94 Cr | ₹2.99 Cr | ₹8.10 Cr |
| Net Worth | ₹1.34 Cr | ₹6.75 Cr | ₹16.38 Cr |
The FY2026 numbers show that the company entered the IPO with substantially higher revenue, profitability and net worth than it had reported two years earlier.
Where Will the IPO Money Be Used?
According to the available issue information, a major portion of the IPO proceeds is planned for working capital requirements. The company also intends to use funds for business development and digital marketing activities, along with general corporate purposes.
| Particular | Amount |
|---|---|
| Working Capital | ₹13.75 Cr |
| Business Development & Digital Marketing | ₹7.50 Cr |
| General Corporate Purposes | Balance amount |
Business and Market Position
Himalaya Nutravedics India operates across Ayurvedic and nutraceutical products and has a distribution presence across multiple Indian states. Its business model combines branded products with contract manufacturing, which provides exposure to more than one revenue channel. The company also reports certifications including ISO 22000:2018, ISO 9001:2015 and WHO-GMP.
The company's recent revenue growth has been supported by expansion in its product and distribution activities. At the same time, investors need to consider factors such as customer concentration, working-capital requirements and historical operating cash-flow performance when assessing the issue.
Himalaya Nutravedics India IPO Timeline
The IPO is scheduled to open on September 22 and close on September 24. The basis of allotment is expected on September 25, followed by refunds and demat credit on September 28. The proposed listing date is September 29, 2026.
With the subscription window opening tomorrow and GMP currently at ₹0, the next important updates will be the day-wise subscription figures and any movement in the grey market premium after bidding begins.
Note: IPO GMP is an unofficial indicator and may change quickly. Investors should consider the company's financials, business risks, valuation and the offer documents rather than relying on GMP alone.
Loading comments...